BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32628029)

  • 1. Pheochromocytoma and paraganglioma genetic testing: Psychological impact.
    Martins RG; Carvalho IP
    Health Psychol; 2020 Oct; 39(10):934-943. PubMed ID: 32628029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations.
    Martins RG; Carvalho IP
    J Cancer Educ; 2020 Oct; 35(5):1026-1033. PubMed ID: 31227996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presymptomatic genetic testing in minors at risk of paraganglioma and pheochromocytoma: our experience of oncogenetic multidisciplinary consultation.
    Lahlou-Laforêt K; Consoli SM; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):354-8. PubMed ID: 22517555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center.
    Asban A; Kluijfhout WP; Drake FT; Beninato T; Wang E; Chomsky-Higgins K; Shen WT; Gosnell JE; Suh I; Duh QY
    J Surg Oncol; 2018 May; 117(6):1217-1222. PubMed ID: 29315604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
    Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
    Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probability of positive genetic testing in patients diagnosed with pheochromocytoma and paraganglioma: Criteria beyond a family history.
    Alobuia WM; Ammar S; Tyagi M; Ghosh C; Gunda V; Annes JP; Kebebew E
    Surgery; 2021 Feb; 169(2):298-301. PubMed ID: 33023754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for pheochromocytoma and paraganglioma: SDHx carriers' experiences.
    Martins RG; Carvalho IP
    J Genet Couns; 2021 Jun; 30(3):872-884. PubMed ID: 33604970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.
    Pai R; Manipadam MT; Singh P; Ebenazer A; Samuel P; Rajaratnam S
    APMIS; 2014 Nov; 122(11):1130-5. PubMed ID: 24735130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing in pheochromocytoma or functional paraganglioma.
    Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
    J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma].
    Wu K; Zhang Y; Zhang H; Tan ZH; Guo XH; Yang JM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):634-639. PubMed ID: 30122763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.
    Peczkowska M; Erlic Z; Hoffmann MM; Furmanek M; Cwikla J; Kubaszek A; Prejbisz A; Szutkowski Z; Kawecki A; Chojnowski K; Lewczuk A; Litwin M; Szyfter W; Walter MA; Sullivan M; Eng C; Januszewicz A; Neumann HP
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4818-25. PubMed ID: 18826997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary pheochromocytoma and paraganglioma].
    Musil Z; Vícha A; Zelinka T; Turková H; Labudová T; Kohoutová M; Pacák K
    Klin Onkol; 2012; 25 Suppl():S21-6. PubMed ID: 22920202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
    Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile-onset hereditary pheochromocytoma-paraganglioma syndrome.
    Sugisawa C; Okada Y; Arao T; Mori H; Nishida K; Isobe K; Takekoshi K; Tanaka Y
    Intern Med; 2013; 52(2):281-4. PubMed ID: 23318864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.
    Cascón A; López-Jiménez E; Landa I; Leskelä S; Leandro-García LJ; Maliszewska A; Letón R; de la Vega L; García-Barcina MJ; Sanabria C; Alvarez-Escolá C; Rodríguez-Antona C; Robledo M
    Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Informing Patients About New Genetic Testing.
    Romero Arenas MA; Grubbs EG
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):559-560. PubMed ID: 30617867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.